Mainstreaming Addiction Treatment Act of 2021

S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions H.R. 6087, Improving Access to Workers Compensation for Injured Federal Workers Act of 2022, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act of 2021, all provisions H.R. 5030, Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, all provisions H.R. 1384, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions S. 445, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions H.R. 2067, Medication Access and Training Expansion (MATE) Act of 2021, all provisions S. 2235, Medication Access and Training Expansion (MATE) Act of 2021, all provisions H.R. 6072, Leveraging Integrated Networks in Communities (LINC) To Address Social Needs Act of 2021, provisions relating to social determinants of health, impact on mental health and social services S. 509, Leveraging Integrated Networks in Communities (LINC) To Address Social Needs Act of 2021, provisions relating to social determinants of health, impact on mental health and social services H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions S. 104, Improving Social Determinants of Health Act of 2021, all provisions S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act, all provisions H.R. 8, Bipartisan Background Checks Act of 2021, all provisions H.R. 1446, Enhanced Background Checks Act of 2021, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 2163, Safe Step Act, all provisions S. 464, Safe Step Act, all provisions H.R. 666, Anti-Racism in Public Health Act of 2021, all provisions S. 162, Anti-Racism in Public Health Act of 2021, all provisions H.R. 5248, Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021, all provisions H.R. 6311, Comprehensive Addiction Resources Emergency Act of 2021, all provisions S. 3418, Comprehensive Addiction Resources Emergency Act of 2021, all provisions H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 3735, Parity Implementation Assistance Act, all provisions H.R. 7232, 9-8-8 and Parity Assistance Act of 2022, all provisions H.R. 7116, 9-8-8 Implementation Act of 2022, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions S. 4090, Dietary Supplement Listing Act of 2022, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions S. 610, Dr. Lorna Breen Health Care Provider Protection Act, all provisions H.R. 3753, Parity Implementation Assistance Act, all provisions S. 1962, Parity Implementation Assistance Act, all provisions S. 3904, Healthcare Cybersecurity Act of 2022, all provisions H.R. 4128, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions H.R. 6000, Cures 2.0 Act, all provisions S. 2416, New Opportunities for Value that Extend Lives (NOVEL) Act of 2021, all provisions H.R. 8152, To provide consumers with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement, all provisions H.R. 2377, Federal Extreme Risk Protection Order Act of 2022, all provisions H.R. 7910, Protecting Our Kids Act, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions H.R. 7667, Food and Drug Amendments of 2022, all provisions H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022, all provisions H.R. 2503, Social Determinants Accelerator Act of 2021, all provisions S. 3039, Social Determinants Accelerator Act of 2021, all provisions H.R. 7192, Diagnostic Device Advisory Committee Act, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act of 2021, all provisions H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act, all provisions H.R. 7845, NIH Clinical Trial Diversity Act of 2022, all provisions H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions H.R. 4480, Telehealth Coverage and Payment Parity Act, all provisions H.R. 7573, Telehealth Extension and Evaluation Act, all provisions S. 3593, Telehealth Extension and Evaluation Act, all provisions H.R. 5541, Primary and Virtual Care Affordability Act, all provisions H.R. 1306, National Coronavirus Commission Act of 2021, all provisions S. 412, National Coronavirus Commission Act of 2021, all provisions H.R. 1843, COVID-19 Hate Crimes Act, all provisions S. 937, COVID-19 Hate Crimes Act, all provisions H.R. 3778, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions S. 1976, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions H.R. 6904, Patients Before Profits Act of 2022, all provisions H.R. 7053, Hospital Inpatient Services Modernization Act, all provisions S. 3792, Hospital Inpatient Services Modernization Act, all provisions H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 5224, Preventing Overdoses and Saving Lives Act of 2021, all provisions H.R. 6279, Opioid Treatment Access Act of 2022, all provisions H.R. 7234, Summer Barrow Prevention, Treatment, and Recovery Act, all provisions H.R. 3352, Midwives for MOMS Act of 2021, all provisions H.R. 847, Promoting Digital Privacy Technologies Act, all provisions S. 224, Promoting Digital Privacy Technologies Act, all provisions H.R. 3771, South Asian Heart Health Awareness and Research Act of 2021, all provisions H.R. 7559, Prescription Information Modernization Act of 2022, all provisions H.R. 8289, Banning Misleading Drug Ads Act of 2022, all provisions H.R. 3614, Menstrual Equity For All Act of 2021, all provisions No Surprises Act/implementation Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions 21st Century Cures Act/implementation Maternal mortality Maternal health and inequities/FY 2023 funding Prior Authorization AMA Recovery Plan for Americas Physicians/telehealth/prior authorization/physician burnout/scope Section 2527(b) of the U.S. Innovation and Competition Act (USICA)/Open Access Language Retired Physician Re-entry COVID-19 telehealth flexibilities COVID-19/Vaccine distribution/Vaccines in physician offices Physician burnout and suicide COVID-19/Health Equity/vaccines COVID-19 response/testing/misinformation/therapeutics/Paxlovid Public Health Emergency COVID-19 Health Equity/Men who have sex with men/3-month blood donation use deferral Health Equity/Federally qualified health centers and clinical trials Womens Reproductive Health Medication Abortion Access Diabetes Provider Relief Fund/COVID-19 Electronic Health Records (EHR) Certification Data Privacy Hunger, Nutrition, and Health Digital Health/AI/Digital Therapeutics Monkeypox/testing/vaccination

Client expense: $4,550,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), President of the U.S., SENATE, Vice President of the U.S., White House Office

Issues relating to Substance abuse treatment and prevention, harm reduction, and opioid abuse; The Mainstreaming Addiction Treatment Act (S. 455 / H.R. 1384), including as incorporated into the Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666) and in the Consolidated Appropriations Act, 2023 (H.R. 2617)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reproductive health, physician-patient relationship, and EMTALA issues H.R.1193-Cardiovascular Advances in Research and Opportunities Legacy Act H.R.1195-Workplace Violence Prevention for Health Care and Social Service Workers Act H.R.1205-Improving Mental Health Access from the Emergency Department Act of 2021 H.R.1260-Bipartisan Solution to Cyclical Violence Act of 2021 H.R.1324-Effective Suicide Screening and Assessment in the Emergency Department Act of 2021 H.R.1364-Parity Enforcement Act of 2021 H.R.1384-Mainstreaming Addiction Treatment Act of 2021 H.R.1620-Violence Against Women Act Reauthorization Act of 2021 H.R.3650-Improving Access to Medicare Coverage Act of 2021 H.R.3932-Pioneering Antimicrobial Subscriptions to End Up Surging Resistance Act of 2021 H.R.4555-Oral Health Literacy and Awareness Act of 2021 H.R.5294-Meaningful Access to Federal Health Plan Claims Data Act of 2021 H.R.7666-Restoring Hope for Mental Health H.R.7850-Prevent BLEEDing Act of 2022 H.R.8163-Improving Trauma Systems and Emergency Care Act H.R.8597-Emergency Care Improvement Act H.Res.656-Supporting the designation of September 17, 2021, as National Physician Suicide Awareness Day to raise awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health issues S.445-Mainstreaming Addiction Treatment Act of 2021 S.467-Effective Suicide Screening and Assessment in the Emergency Department Act of 2021 S.1133-Cardiovascular Advances in Research and Opportunities Legacy Act S.2048-Improving Access to Medicare Coverage Act of 2021 S.2076-Pioneering Antimicrobial Subscriptions to End Up Surging Resistance Act of 2021 S.2157-Improving Mental Health Access from the Emergency Department Act of 2021 S.2422-Bipartisan Solution to Cyclical Violence Act S.3566-Improving Trauma Systems and Emergency Care Act S. 4269-Prevent BLEEDing Act S.Res.364-Supporting the designation of September 17, 2021, as National Physician Suicide Awareness Day to raise awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health issues. S.Res.557-A resolution recognizing the week of March 20 through March 26, 2022, as National Poison Prevention Week and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poison prevention.

Client expense: $515,937 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Opioids, pain management Federal funding for Substance Use Disorder treatments H.R.1384-Mainstreaming Addiction Treatment Act of 2021 H.R.4846-ALTO Reauthorization Act of 2021 H.R.8454-Medical Marijuana and Cannabidiol Research Expansion Act S.445-Mainstreaming Addiction Treatment Act of 2021 S.2538-ALTO Reauthorization Act of 2021

Client expense: $515,937 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1384/S. 445 -- Mainstreaming Addiction Treatment Act

Client expense: $35,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1384/S. 445 -- Mainstreaming Addiction Treatment Act

Client expense: $35,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY23 Labor, Health and Human Services, and Education Appropriations Bill: Pediatric Subspecialty Loan Repayment Program, Firearm Injury and Mortality Prevention Research, Pediatric Mental Health Care Access Program, Emergency Medical Services for Children, National Center for Birth Defects and Developmental Disabilities, Global Immunization, Sudden Unexpected Infant Death and Sudden Death in Childhood, Vaccine Injury Compensation Program, VACCINES Act, Antimicrobial Resistance, Maternal and Child Health, School Based Health Centers COVID-19 Supplemental Appropriations H.R.482 / S.350 - Newborn Screening Saves Lives Reauthorization Act FY23 National Defense Authorization Act and Halting Reductions to Military Medical Personnel Defense Health Agency - Autism Care Demonstration H.R.5551 - Improving the Health of Children Act H.R.2347 / S.2691 - Strengthening the Vaccines for Children Program Act of 2021 Childrens Literacy Initiative on Military Bases (CLIMB) Act of 2022 - H.R. 8208 Advancing FASD Research, Services and Prevention Act - S. 2238 / H.R. 4151 Banning Electronic Stimulation Devices - FDA User Fee Bills (H.R. 7667/S. 4348) MIECHV - The Jackie Walorski Maternal and Child Home Visiting Reauthorization Act (H.R. 8876) SSI Savings Penalty Elimination Act (S. 4102) Data on Interactions and Accountability for Law Enforcement with Individuals with Disabilities Act (S. 5107) Augmentative and Alternative Communication Centers to Establish National Training Act (S.2) Equitable Community Access to Pharmacist Services Act (H.R. 7213) Banning electric shock devices Kids Online Safety Act (S. 3663) Children and Teens Online Privacy Protection Act (S. 3663) Privacy and design protections for children and adolescents online Rulemaking Petition on Engagement Optimizing Digital Design Practices Used on Minors Pediatric Subspecialty Loan Repayment Program Implementation (Health Resources and Services Administration) Pediatric Research Priorities at Advanced Research Projects Agency for Health Tobacco Policy Priorities (Flavored products, premarket review, product perception studies) FY 2023 Appropriations for Centers for Disease Control and Prevention Office on Smoking and Health Mainstreaming Addiction Treatment Act (H.R. 1384/S. 445) FY 2023 Funding for National Institutes of Health Accuracy of Pulse Oximetry in Children of Color Gun Violence Prevention Research Funding Child passenger safety (H.R. 5736) Appropriations for the Indian Health Service Maternal, Infant, and Early Childhood Home Visiting Program (including Jackie Walorski MIECHV Reauthorization Act of 2022 (H.R. 8876)) Infant sleep product safety (S. 1259, H.R. 3182) Lead exposure prevention Food safety Paid family and medical leave Regulation of high-powered magnet sets Climate change, Inflation Reduction Act Vehicle Emissions Standards Button battery ingestions (H.R. 5313, S. 3278) Early childhood education Access to genetic sequencing Child product safety and injury prevention Furniture tip-overs (S. 441, H.R. 1314) Child Abuse Prevention and Treatment Act reauthorization, CAPTA Reauthorization Act of 2021 CAPTA Plans of safe care grants Family First Prevention Services Act implementation (House, Senate, ACF) Issues related to the COVID-19 pandemic and providing supports for the child welfare community (House, Senate, and ACF) CAPTA Fatalities Prevention and Response (House, Senate, and HHS) Title IV-B Reauthorization Ensuring Medicaid continuity for Children in Foster Care Act (S. 2689/H.R. 5414) Congregate care reform Mental health supports for foster youth/former foster youth Indian Child Welfare Act & Title IV-B (H.R. 8954) Mercury and Air Toxics Standards, ozone and particulate matter NAAQS, EPA greenhouse gas regulation Appropriations - global child and youth-focused global health subaccounts at USAID (Vulnerable Children, Maternal and Child Health, Nutrition) Global Child Thrive Act Implementation Strengthening Efforts to End Violence Against Children Act Reach Every Mother and Child Act International Children with Disabilities Protection Act Standards in ORR Custody Licensure of ORR Shelters Public Charge Child Nutrition Reauthorization/WIC SNAP Mental Health for Children H.R. 6, DREAM Act Medical Nutrition Equity Act Donor Human Milk Lift the Bar Act CARE for Families Act HR 3107 WIC Act Breastfeeding Peer Counseling Program Public Health Preparedness and Response Research for Pregnant and Lactating Women Funding for Pediatric Device Consortia Funding for Emergency Medical Services for Children Program Funding for HRSA Pediatric Mental Health Care Access Program PUMP Act DEMAND Act Dietary Guidelines Child Poverty Coronavirus Response Legislation Child Poverty Reduction Act Suicide Prevention Child Nutrition Waivers School Meal Standards WIC Food Packages Universal School Meals Equality Act Mental Health Services for Students Act Youth Mental Health and Suicide Prevention Act Child Tax Credit Supporting Childrens Mental Health Care Access Act Infant Formula Shortage White House Conference on Hunger, Nutrition, and Health Mental Health Reform Reauthorization Act Restoring Hope for Mental Health and Well-Being Act Gender Affirming Care Safety of Pediatricians and Childrens Hospitals Emergency Vacating of Aircraft Cabin (EVAC) Act Same Day Billing Restrictions in Mental Health Senate Finance Committee Mental Health Discussion Drafts 12-Month Continuous Eligibility for Children in Medicaid/CHIP Easy Enrollment in Health Care Act of 2021 (Senate) Accelerating Kids Access to Care Act (H.R. 3089/S. 1544) Connect for Health Act of 2021 Medicaid Payment Parity H.R. 2347, Strengthening the Vaccines for Children Program Act HR 1025, the Kids Access to Primary Care Act S. 1833 The Ensuring Access to Primary Care for Women and Children Act of 2021 Medicaid Maintenance of Effort (MOE) Protections Comprehensive Access to Robust Insurance Now Guaranteed (CARING) for Kids Act (H.R.66) H.R. 1791 Childrens Health Insurance Program Permanency (CHIPP) Act Stabilize Medicaid and CHIP Coverage Act (H.R. 1738) Permanent CHIP Funding Extension Permanent Extension of Express Lane Eligibility Option Medicaid Reentry Act Medicaid Funding for the Territories HR 3089/S 1544 The Accelerating KidsAccess to Care Act (AKACA) Expanding Medicaid HCBS Services for Children Access to Care in Medicaid/CHIP Maternal Health H.R. 4996 Helping Moms Act H.R.4995 - Maternal Health Quality Improvement Act of 2020 Postpartum Medicaid Extension and Maternal Health Improvements Closing the Medicaid Coverage Gap Adult Medicaid Vaccine Access Increased Funding for Childrens Hospitals Graduate Medical Education COVID-19 Response (House, Senate, HHS, CMS) Medicaid/CHIP Eligibility Redeterminations post PHE Medicaid Unwinding Payment for COVID-19 Vaccine Counseling Coding Changes for COVID-19 Counseling Payment

Client expense: $200,000 · Firm income: Not reported

Government targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, U.S. Agency for International Development (USAID), White House Office

Legislation and policies related to: Prescription and administration of buprenorphine and other medication assisted treatment by nurses and advanced practice registered nurses for the treatment of opioid or substance use disorders H.R. 1384/S. 445, Mainstreaming Addiction Treatment Act of 2021 H.R. 2067, Medication Access and Training Expansion (MATE) Act

Client expense: Not reported · Firm income: $24,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Mainstreaming Addiction Treatment Act (S. 445/H.R. 1384), all provisions related to removing the waiver requirement for health care providers to prescribe buprenorphine for opioid use disorder. Improving Access to Remote Behavioral Health Treatment Act of 2019, all provisions related to amending regulations for the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and allowing community mental health centers to register to practice telemedicine. Medication Access and Training Expansion Act (H.R. 2067), all provisions related to requiring physicians and other prescribers of controlled substances to complete training on treating and managing patients with substance use disorders. CONNECT for Health Act of 2021 (H.R. 2903/S. 1512), all provisions related to expanding access to telehealth services. Telemental Health Care Access Act of 2021 (S. 2061), all provisions related to ensuring coverage of mental health services furnished through telehealth. HELP Act of 2021 (S. 1570), all provisions related to the accessibility and coordination of 211 services and 988 services. Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708/S. 168), all provisions related to temporary authorization of in-person and telehealth services. Behavioral Health Crisis Services Expansion Act (S. 1902), all provisions related to empowering communities to establish a continuum of care for individuals experiencing a behavioral health crisis. Preventing Overdoses and Saving Lives Act of 2021 (H.R. 5442), all provisions related to authorizing grants to develop strategic response plans with respect to the opioid crisis, and to require practitioners prescribing an opioid for certain patients to also prescribe an opioid overdose reversal drug. Coronavirus Mental Health and Addiction Assistance Act of 2021 (H.R. 593/S. 135), all provisions related to providing grants to entities that provide mental health and substance use disorder programs during the COVID-19 pandemic. Mental Health Services for Students Act of 2021 (H.R. 721/S. 1841), all provisions related to school-based mental health services. Stopping the Mental Health Pandemic Act (H.R. 7080/S. 4059), all provisions related to grants to support behavioral health treatment and services during the COVID-19 pandemic. Emergency Support for Substance Use Disorders Act (S. 4058), all provisions related to grants for harm reduction activities during the COVID-19 pandemic. Elementary and Secondary School Counseling Act (H.R. 6214/S. 3356), all provisions related to awarding grants to increase access to school-based, mental health services. Campus Prevention and Recovery Services for Students Act of 2019 (H.R. 3591), all provisions related to expanding the illicit drug and alcohol abuse prevention program to include campus efforts to prevent substance misuse. Opioid Treatment Access Act of 2022 (H.R. 6279), all provisions related to authorizing a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs. 9-8-8 Implementation Act of 2022 (H.R. 7116), all provisions related to providing for improvements in the implementation of the National Suicide Prevention Lifeline, and for other purposes. 9-8-8 and Parity Assistance Act of 2022 (H.R.7232), all provisions related to providing for improvements in the implementation of the National Suicide Prevention Lifeline, and for other purposes. Into the Light for MMH and SUD Act of 2022 (H.R. 7073), all provisions related to reauthorizing a grant program for screening, assessment, and treatment services for maternal mental health and substance use disorders, and for other purposes. Anna Westin Legacy Act (H.R. 7249/S. 3686), all provisions related to providing education and training on eating disorders for health care providers and communities, and for other purposes. Behavioral Health Information Technology Act, (H.R.7427), all provisions related to CMI testing of incentive payments for behavioral health providers and certain other providers for adoption and use of certified electronic health record technology, and for other purposes Safe Step Act (H.R. 2163/S. 464), all provisions related to creating an exception for medication step-therapy. Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act (S. 586), all provisions related to establishing separate payments for certain non-opioid treatments under the Medicare prospective payment system for hospital outpatient department services and the payment system for ambulatory surgical center services Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348), all provisions related to addressing substance use disorders and the safe disposal of opioids. Telemental Health Access to Care Act (S.2061/H.R. 4058), all provisions related to intended to increase access to tele-mental health care and telehealth. Stop Pills That Kill Act (S.4151), all provisions related to penalizing the manufacture and/or facilitation of manufacturing counterfeit pills that contain fentanyl, an analogue of fentanyl, or a counterfeit substance. Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666), all provisions related to reauthorizations, expansions, and modifications of programs, grants, and activities that focus on mental and behavioral health. CONNECT Act of 2022 (H.R.8391), all provisions related to awarding grants for crisis centers to provide follow-up services to individuals receiving suicide prevention and crisis intervention services. BENEFIT Act of 2021 (H.R.4472), all provisions related to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs. Advancing Telehealth Beyond COVID-19 Act of 2021 (H.R.4040), all provisions related to extending telehealth flexibilities under the Medicare program Expanding Access to Mental Health Training Act (S. 4461), all provisions related to reauthorizing grants for training teachers and other school personnel to recognize the symptoms of childhood and adolescent mental health disorders. Behavioral Health Network and Directory Improvement Act (S. 5093), all provisions related to protect patients and improve the accuracy of provider directory information by eliminating ghost networks. Any legislation published by the Senate Finance Committee relating to behavioral healthcare, including workforce, mental health integration, and parity policy.

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Communications Commission (FCC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE

Support for public health infrastructure Personal Protective Equipment Standards and access to Personal Protective Equipment, including supply chain issues Mental health resources for nurses S.308/H.R.1436 ‐ PPE in America Act H.R. 1384/S.445 - Mainstreaming Addiction Treatment (MAT) Act Issues surrounding telehealth, including removal of Medicare originating site and rural area restrictions S.610/H.R.1667 ‐ Dr. Lorna Breen Health Care Provider Protection Act H.R. 851/S.246 ‐ Future Advancement of Academic Nursing (FAAN) Act Issues surrounding nurse staffing shortages and remedies to address this crisis Pandemic preparedness S.3799 ‐ PREVENT Pandemics Act Extension of COVID‐19 public health emergency H.R. 7666 - Restoring Hope for Mental Health and Well‐Being Act of 2022 H.R. 8812 - Improving Care and Access to Nurses (ICAN) Act S.5212 - Improving Care and Access to Nurses (ICAN) Act Issues surrounding federal Monkeypox response

Client expense: $423,637 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Support for public health infrastructure Personal Protective Equipment Standards and access to Personal Protective Equipment, including supply chain issues Mental health resources for nurses S.308/H.R.1436 ‐ PPE in America Act H.R. 1384/S.445 - Mainstreaming Addiction Treatment (MAT) Act Issues surrounding telehealth, including removal of Medicare originating site and rural area restrictions S.610/H.R.1667 ‐ Dr. Lorna Breen Health Care Provider Protection Act H.R. 851/S.246 ‐ Future Advancement of Academic Nursing (FAAN) Act Issues surrounding nurse staffing shortages and remedies to address this crisis Pandemic preparedness S.3799 ‐ PREVENT Pandemics Act Extension of COVID‐19 public health emergency H.R. 7666 - Restoring Hope for Mental Health and Well‐Being Act of 2022 H.R. 8812 - Improving Care and Access to Nurses (ICAN) Act S.5212 - Improving Care and Access to Nurses (ICAN) Act Issues surrounding federal Monkeypox response

Client expense: $380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Lobbying Report: October 1 - December 31, 2022 (Action Fund) GHAI Overdose Initiative (under healthcare issue code): Legislation: H.R. 1384/S. 455 Mainstreaming Addiction Treatment Act H.R. 7666 Restoring Hope for Mental Health and Substance Use Act H.R.2617 - Consolidated Appropriations Act, 2023 Issues: Inequity in the opioid treatment system Increasing access to evidence-based treatment for substance use disorder Agencies Visited: US Senate Centers for Disease Control and Prevention US House of Representatives ONDCP SAMHSA DEA CDC

Client expense: $230,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Opioid Treatment Access Act (S. 3629/H.R. 66279) Mainstreaming Addiction Treatment Act (S. 445, H.R. 1384) Consolidated Appropriations Act, 2023 (H.R. 2617)

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities. Draft Graduate Medical Education Reform Act Issue: Support increased funding for the National Health Service Corps, Teaching Health Center GME, and National Disaster Medical Service (NDMS) demonstration pilot. Support increased Medicare support for Graduate Medical Education/physician training. Issues: Educate Congress and the administration about the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support measures to expand access to mental health care and substance use disorder treatment, including funding for training on substance use disorders, pain management, and safe prescribing practices, enhance enforcement of mental health parity laws, increased financial support for integrated behavioral health models. Support the provision of additional Medicare-supported graduate medical education slots for psychiatry and psychiatry sub-specialties. P.L. 117-328, Consolidated Appropriations Act, 2023 Support the provision of 200 additional Medicare-supported graduate medical education (GME) positions. Support the extension of COVID-related telehealth flexibilities. Support elimination or delay of Statutory Pay-As-You-Go (PAYGO) Medicare sequester and eliminating or reducing scheduled cuts to the Physician Fee Schedule. Support one-year of continuous Medicaid coverage for children. Support extension of postpartum Medicaid and CHIP coverage for 12 months. H.R. 1384/ S.445, Mainstreaming Addiction Treatment (MAT) Act of 2021 P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF Issue: Support suspension of waiver requirement for certain providers to prescribe buprenorphine. H.R. 2067, Medication Access and Training Expansion (MATE) Act of 2021 P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF Issue: Oppose legislative mandates dictating medical education curriculum on pain management and addiction. H.R. 7236, Strengthen Kids Mental Health Now Act/ S. 2727 Investing in Kids Mental Health Now Act Issue: Support increasing Medicaid reimbursement rates for pediatric mental health services through a 100% federal match. P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels. Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers to fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including restrictions on covered entities use of contract pharmacy to distribute covered drugs. H.R. 4390, Preserving Rules Ordered for the Entities Covered Through 340B Act of 2021 (PROTECT 340B Act) Issue: Support measures to prevent pharmacy benefit managers and commercial insurers from discriminating against 340B covered entities. H.R. 3203/S. 773 Issue: Support policy to allow 340B DSH hospitals to remain eligible to participate in the program throughout the current public health emergency even if their DSH adjustment falls below the current threshold due to changes in payer mix as a result of the COVID-19 pandemic. Issue: Oppose insurance plans that do not meet Affordable Care Act requirements. Issue: Support increased interoperability and exchange of electronic health information and delayed enforcement of information blocking rule until comprehensive guidance is issued. Issue: Support the ongoing refinement of the two new mandatory alternative payment models, the Radiation Oncology Model and End-stage Renal Disease Treatment Choices Model, to better incentivize high-quality care for all patients. H.R. 4128/ S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 P.L. 117-328, Consolidated Appropriations Act, 2023 Issue: Educate Congress on development of Laboratory Developed Tests at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing Food and Drug Administration regulation of the development of Laboratory Developed Tests at academic medical centers. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 H.R. 7667, Food and Drug Amendments of 2022 (FDA22) P.L. 117-328, Consolidated Appropriations Act, 2023 Issue: Support promotion of data sharing and clinical trials results reporting. Support increased clinical trials diversity. Issue: Development of Enhanced Primary Care Pilot Act proposal H.R. 2503 / S. 3039, Social Determinants Accelerator Act of 2021 Issue: Support grants to address social determinants of health H.R. 7585 / S. 4486, Health Equity and Accountability Act Issue: Support programs to improve health equity and address social determinants of health. Issue: Support incentives to encourage the inclusion of implicit bias training in medical education and residency training. Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health. Issue: Support maternal health initiatives to expand coverage during the postpartum period and expand demonstration project grants. H.R. 959, Black Maternal Health Momnibus Act of 2021 S. 1695 / H.R. 4387, Maternal Health Quality Improvement Act S. 1491/ H.R. 769, Rural MOMs Act H.R. 4387, Maternal Health Quality Improvement Act of 2021 H.R. 925 / S. 347, Data to Save Moms Act Issue: Support legislative efforts to improve maternal health and reduce rates of maternal mortality, including the Momnibus. Support legislative initiatives to improve data collection to improve maternal health equity. P.L. 117-159, Bipartisan Safer Communities Act Issue: Support policies to promote firearm safety, universal background checks, violence prevention programs, extreme risk protection orders, child access safety laws, reinstating assault weapons ban, data infrastructure, hospital based and community violence intervention programs, and programs to address mental and behavioral health impact of gun violence. Issue: Support funding for Community Violence Interventions / Hospital Based Violence Intervention Programs P.L. 117-105, Dr. Lorna Breen Health Care Provider Protection Act Issue: Support grants directed at improving clinician burnout and well-being. Issue: Provide feedback on implementation of the Provider Relief Fund. Support extension for use of PRF funds. Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs, including delaying recoupment of MAAP loans. Issue: Support extension of public health emergency declaration. Issue: Provide feedback on COVID-19 and pandemic response. Provide feedback on monkeypox response including testing. S. 3799, PREVENT Pandemics Act P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF Issue: Provide feedback on pandemic preparedness legislation, urge inclusion of provisions to support academic medical centers preparedness activities. Issue: Support establishment of regional pandemic response centers, stronger linkages between public health and academic medicine, and the role of medical students and academic medical centers in administering COVID vaccines. Issue: Support efforts of academic medical centers to respond to public health threats such as monkeypox and COVID-19. Urge establishment and implementation of robust national testing strategy; functional, redundant, and transparent supply chain; improved federal coordination; investments in public health and health care human and other resources; data modernization initiatives; and other actions to improve current and future pandemic response. H.R. 708, S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout the COVID-19 public health emergency S. 674 Public Health Infrastructure Saves Lives Act Issue: Support investments in core public health infrastructure. Issue: Support ensuring patients are put first, that conscience protections align with medical professionalism standards, and oppose interference in the patient-physician relationship. Issue: Support increased interoperability and exchange of electronic health information. Support delay of enforcement beyond April 2021. H.R. 6000, Cures 2.0 Act Issue: Provide feedback on provisions related to public health, patients and caregivers, FDA, CMS, and research, and ARPA-H. Issue: Promote strategies to strengthen the health, public health, and research workforces. H.R. 3671, Doctors of Community Act Issue: Discuss authorization of the Teaching Health Center Graduate Medical Education program. H.R. 8131, Increasing Competition for Medical Residency Act Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency. Issue: Provide guidance on the implementation of the No Surprises Act. Issue: Provide feedback on proposed modifications to the HIPAA privacy rule. H.R. 5035 / S. 2982, Child Suicide Prevention and Lethal Means Safety Act Issue: Support legislation to provide grants to improve suicide prevention and lethal means safety. Issue: Inform Congress and Administration about medical education on caring for older adults, nutrition, climate change, stigma around addiction, reproductive health, and accelerated medical education training programs. Issue: Provide feedback on efforts of the academic medicine community to address climate change and decarbonization. Issue: Support efforts of teaching hospitals to promote patient safety and high-quality care. H.R. 7152/ S.3534, The Tracking Pathogens Act P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF Issue: Support expansion of CDC activities related to genomic sequencing of pathogens. Issue: Support reignition of Cancer Moonshot. H.R. 7961, Safety from Violence for Healthcare Employees (SAVE) Act Issue: Support statutory protections against violence and intimidation for health care workers and provide grants for hospital programs aimed at preventing violence in health care settings. P.L. 117-263, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 Issue: Support a one year pause in military medical billet reductions in the Military Health System.

Client expense: $876,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Vice President of the U.S., White House Office

Implementation of funding provided for in Consolidated Appropriations Act, 2021 (P.L. 116-260) to address substance use disorder; Mainstreaming Addiction Treatment Act (H.R. 1384/S. 445); Medication Access and Training Expansion Act (H.R. 2067/S. 2235); Medicaid Reentry Act of 2021 (H.R. 955/S. 285); Collaborate in an Orderly and Cohesive Manner Act (H.R.5218); Comprehensive Addiction Resources Emergency Act of 2021 (H.R. 6311/S. 3418); Synthetic Opioid Danger Awareness Act (H.R. 2364); FENTANYL Results Act (H.R. 2538/S. 1160); issues related to fentanyl; Consolidated Appropriations Act, 2023 (P.L. 117-328).

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, provisions relating to fraud, waste, and abuse S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, provisions relating to fraud, waste, and abuse H.R. 2617, Consolidated Appropriations Act, 2023, provisions relating to COVID-19 telehealth flexibilities H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 3753, Parity Implementation Assistance Act, all provisions S. 1962, Parity Implementation Assistance Act, all provisions S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act, provisions relating to hospital-at-home flexibilities H.R. 925, Data to Save Moms Act, all provisions H.R. 959, Black Maternal Health Momnibus Act of 2021, all provisions S. 346, Black Maternal Health Momnibus Act of 2021, all provisions H.R. 6878, Pregnant Women in Custody Act, all provisions S. 5027, Protecting the Health and Wellness of Babies and Pregnant Women in Custody Act, all provisions H.R. 1384, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions S. 445, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions H.R. 2067, Medication Access and Training Expansion (MATE) Act of 2021, all provisions S. 2235, Medication Access and Training Expansion (MATE) Act of 2021, all provisions H.R. 7234, Summer Barrow Prevention, Treatment, and Recovery Act, all provisions H.R. 8908, Fighting Stimulant and other Substance Use Disorders Act, all provisions H.R. 8891, No Surprises for Survivors Act of 2022, al provisions H.R. 8885, Better Health Care Directories Act, all provisions H.R. 8886, Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act, all provisions H.R. 8892, Access to Mental Health Services Act, all provisions H.R. 8881, Mental Health Transparency Act, all provisions H.R. 8889, Readable Insurance Coverage Explanations (RICE) Act, all provisions S. 5041, Training Psychiatrists for the Future Act, all provisions H.R. 1218, Data Mapping to Save Moms Lives Act, all provisions S. 198, Data Mapping to Save Moms' Lives Act, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 1446, Enhanced Background Checks Act of 2021, all provisions H.R. 8, Bipartisan Background Checks Act of 2021, all provisions H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions S. 104, Improving Social Determinants of Health Act of 2021, all provisions H.R. 2163, Safe Step Act, all provisions S. 464, Safe Step Act, all provisions H.R. 5248, Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021, all provisions H.R. 5602, Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act of 2021, all provisions S. 3244, Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act of 2021, all provisions H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions S. 3904, Healthcare Cybersecurity Act of 2022, all provisions H.R. 4128, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions H.R. 6000, Cures 2.0 Act, all provisions H.R. 8152, American Data Privacy and Protection Act, all provisions H.R. 2377, Federal Extreme Risk Protection Order Act of 2022, provisions related to gun violence H.R. 7910, Protecting Our Kids Act, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions H.R. 7667, Food and Drug Amendments of 2022, all provisions H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022, all provisions H.R. 8318, To restrict limitations on the possession, sale, purchase, transportation or use of any contraceptive that relates to interstate commerce, all provisions H.R. 8296, Womens Health Protection Act of 2022, all provisions H.R. 8297, Ensuring Womens Right to Reproductive Freedom Act, all provisions H.R. 8373, Right to Contraception Act, all provisions H.R. 1235, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R. 3301, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, all provisions S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials Act of 2021, all provisions H.R. 5030, Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, all provisions H.R. 6072, Leveraging Integrated Networks in Communities (LINC) To Address Social Needs Act of 2021, all provisions S. 509, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021, all provisions H.R. 666, Anti-Racism in Public Health Act of 2021, all provisions S. 162, Anti-Racism in Public Health Act of 2021, all provisions H.R. 6311, Comprehensive Addiction Resources Emergency Act of 2021, all provisions S. 3418, Comprehensive Addiction Resources Emergency Act of 2021, all provisions H.R. 7232, 9-8-8 and Parity Assistance Act of 2022, all provisions S. 4090, Dietary Supplement Listing Act of 2022, all provisions No Surprises Act/implementation Hospice Code Modernization Act of 2022 Cybersecurity Climate change and inhalers WIC/Nutrition Opioids/Pain Care and Substance Use Disaster funding/Puerto Rico and Florida Gender reassignment surgery/provider threats Health Equity Long-term care/special needs Data Privacy Prior authorization Artificial Intelligence(AI)/Bias/Equity Digital health/AI/Digital therapeutics Maternal mortality and morbidity/Equity Infectious disease - COVID-19, monkey pox, RSV COVID-19/testing/misinformation/vaccines/therapeutics Opioids Reproductive health Cannabis/marketing/unapproved medical claims Emergency departments/patient boarding Precision medicine/diagnostics Section 1557/nondiscrimination

Client expense: $5,060,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

Federal response to COVID-19, Medicare reimbursement and incident to billing, Medicare hospice restrictions, telehealth, transparency, healthcare competition, coverage and access to mental health services, Promoting Access to Diabetic Shoes Act (S 800, HR 4870), the Mainstreaming Addiction Treatment Act (S 445, HR 1384), the Increasing Access to Quality Cardiac Rehabilitation Care Act (S 1986, HR 1956), the Improving Care and Access to Nurses Act (HR 8812), training requirements included in the Medication Access and Training Expansion Act (HR 2067), the Restoring Hope for Mental Health and Well-Being Act (HR 7666), ACO Assignment Improvement Act (HR 6308), PA Educational and Workforce Training Programs, federal workers compensation exams and covered treatment (HR 6087), Consolidated Appropriations Act, 2023 (HR 2617), federal PA workforce issues at the Departments of Veterans Affairs, Indian Health Services, expanding access to primary care and behavioral health services.

Client expense: $160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Veterans Affairs, Dept of (VA), White House Office

HR 432 and S 828 To provide for the coverage of marriage and family therapist services and mental health counselor services under Medicare. HR 708 and S 168 To provide temporary licensing reciprocity for telehealth and interstate health care treatment. HR 1384 and S 445 Loosens restrictions on doctors prescribing buprenorphine for addiction treatment. HR 2503 To direct the HHS Secretary to establish an interagency council on social determinants of health. S 660 Improves access to tele-mental health during the length of the COVID-19 PHE. S 674 To support public health infrastructure (funding up to $4.5 billion). HR 2255/S. 1024 To recapture unused immigrant visas and allocate them to doctors and nurses to help in the fight against COVID-19. HR 2903/S. 1512 Comprehensive bill to expand telehealth access and make permanent telehealth flexibilities available during COVID-19 pandemic. HR 3203/S. 773 To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program. S. 1162 To expand access to Programs of All-Inclusive Care for the Elderly (PACE). HR 4118 To authorize the HHS Secretary to invest in community-based violence reduction initiatives. S. 2257 To reduce drug and device shortages and costs. HR 5801 To apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans. Health care workforce shortage concerns. S. 3626 To improve access to the Program of All-Inclusive Care for the Elderly (PACE) HR 7236 To expand the availability of mental, emotional, and behavioral health services under the Medicaid program HR 7353 To treat telehealth services as excepted benefits HR 7961 To protect hospital personnel from violence S 4352 To require a study on the effects of travel nurse agencies on the health industry during the COVID-19 pandemic S 3189 To provide a pathway to health careers through health profession opportunity grants HR 7666 Reauthorizes, expands, and modifies programs, grants, and activities that focus on mental and behavioral health

Client expense: $200,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.800/H.R. 4870 - Promoting Access to Diabetic Shoes Act H.R. 1956/S. 1986 - Increasing Access to Quality Cardiac Rehabilitation Care Act of 2021 H.R. 2067/S. 2235 - Medication Access and Training Expansion (MATE) Act S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0 H.R. 1319 - American Rescue Plan Act [Public Law No: 117-2] H.R. 1716 - COVID-19 Mental Health Research Act H.R. 1195 - the Workplace Violence Prevention for Health Care and Social Service Workers Act S. 54 - Strengthening Americas Health Care Readiness Act H.R. 851/S. 246 - the Future Advancement of Academic Nursing (FAAN) Act H.R. 959/S.346 - Black Maternal Health Momnibus Act of 2021 H.R. 1384 - the Mainstreaming Addiction Treatment Act of 2021 H.R. 955 - the Medicaid Reentry Act of 2021 H.R. 1025 - the Kids Access to Primary Care Act of 2021 S. 1315/H.R. 3630 - the Lymphedema Treatment Act S. 1833 - the Ensuring Access to Primary Care for Women & Children Act H.R. 3550/S. 4905 - the Primary and Behavioral Health Care Access Act S. 1512/H.R. 2903 - the CONNECT for Health Act of 2021 S. 287/H.R. 945 - the Perinatal Workforce Act S. 1536/H.R. 3108 - the Medical Nutrition Therapy Act of 2021 H.R. 1667/S. 610 - the Dr. Lorna Breen Health Care Provider Protection Act H.R. 736 - the Community Immunity During COVID-19 Act of 2021 H.R. 3087/S. 2051 - Breast Cancer Patient Equity Act H.R. 6000 - the Cures 2.0 Act S. 2652/H.R. 5067 - the Preserving Patient Access to Home Infusion Act S. 3149/H.R. 5848 - the Rural Health Equity Act H.R. 6308 - the ACO Assignment Improvement Act of 2021 H.R. 5248 - the Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021 H.R. 5376 - the Build Back Better Act H.R.3925 - the Reducing Barriers to Substance Use Treatment Act S. Res. 626 and H. Res. 1100 - honoring and recognizing May 6 through 12, 2022 as National Nurses Week S.3098/H.R. 7617 - Preventive Care Awareness Act S.4182 - the Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7236 - the Strengthen Kids Mental Health Now Act of 2022 H.R. 2376 - the Excellence in Recovery Housing Act H.R. 4944 - the Helping Kids Cope Act of 2021 H.R. 5218 - the Collaborate in an Orderly and Cohesive Manner Act H.R. 7076 - the Supporting Childrens Mental Health Care Access Act of 2022 H.R. 7232 - the 9-8-8 and Parity Assistance Act of 2022 H.R.7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.4170 - the Mental Health Reform Reauthorization Act H.R. 8812/S. 5212 - Improving Care and Access to Nurses (ICAN) Act H.R. 8454 - Medical Marijuana and Cannabidiol Research Expansion Act [Public Law No: 117-215] H.R. 3352/S. 1697 - Midwives for MOMs Act H.R. 8817/S. 4844 - the National Nursing Workforce Center Act of 2022 H.R. 3259/S. 586 - the NOPAIN Act H.R. 2617 - Consolidated Appropriations Act, 2023 The Senate Finance Committee Bipartisan Mental Health Workforce Discussion Draft National Healthcare Provider Directory Department of Labor independent contractor classification Issues pertaining to White House Hunger, Nutrition, and Health Conference Issues surrounding federal Monkeypox response Clinical Laboratory Improvement Amendments (CLIA) Replenish the COVID-19 Uninsured Relief Fund Nursing faculty shortage Nursing Education Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Rural health care issues, including rural workforce, COVID-19 vaccination, and reimbursement Medicare sequestration Medicare restrictions pertaining to telehealth Include nurses, APRNs, and nursing students in all National Public Health Plans Provide resources to support nurses, APRNs, and nursing students mental health needs, especially for those responding to the pandemic Funding to ensure childcare coverage Increased Federal Medical Assistance Percentage (FMAP) funding to states Access to personal protective equipment Extension of CMS waivers beyond public health emergency Skilled Nursing Facility admitting examination and assessment requirements COVID-19 Pandemic relief: funding, removal of barriers, telehealth, mental health, personal protective equipment, and testing Telehealth, remote patient monitoring and other forms of health technology COVID-19 Pandemic Reducing Regulatory Burdens, including those relating to home infusion therapy, Medicare Conditions of Participation, and hospice certification Medication-Assisted Treatment (MATs) Opioid Abuse Epidemic Documentation of medical records Health plan coverage and program requirements including provider non-discrimination Issues relating to Mental and Substance Use Disorder Workforce Addressing Health Equity Medicare Provider Reimbursement Clinical labor pricing update Tobacco flavors and menthol Site specific restrictions on providers under DEA controlled substances policy

Client expense: $320,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Nuclear Regulatory Commission (NRC), Office of Special Counsel, SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

HR955/S285, Medicaid Reentry Act, HR1384/S445 Mainstreaming Addiction Treatment Act; HR2067 Medication Access and Training Expansion Act; S5000 CARA 2.0 Act, FY2023 Labor-HHS-Education and Commerce-Justice-Science Appropriations; HR 7666, Restoring Hope for Mental Health and Well-being Act of 2022; HR 7667, FDA User Fee Amendments of 2022; S 4348, FDASLA Act of 2022; HR 2617, Consolidated Appropriations 2023.

Client expense: $250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

- Telehealth issues - Medicare reimbursement including "incident to" billing; Medicare hospice restrictions; transparency; veterans' health care; opioid addiction treatment; mental health. - HR 1384, S. 445 - Mainstreaming Addiction Treatment Act - HR 2067 - Medication Access and Training Expansion (MATE) Act - S. 800, H.R. 4870 - promoting access to diabetic shoes - HR 6308 - ACO Assignment Improvement Act of 2021 - HR 1956, S. 1986 - Increasing Access to Quality Cardiac Rehabilitation Care Act - HR 6087 - Improving Access to Workers Compensation for Injured Federal Workers Act - HR 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022 - HR 2617, Consolidated Appropriations Act, 2023

Client expense: Not reported · Firm income: $60,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Athlete safety; Opioid misuse/abuse prevention; Athlete trainers under Medicare program; H.R. 5216 - Protecting Student Athletes from Concussions Act; H.R. 4855 - Braedens Commission: Protect Our Athletes from Exertional Heat Stroke; Concussion Awareness and Education Act; S. 844, H.R. 3109 - The Personal Health Investment Today (PHIT) Act; S. 1301, H.R. 2094 - The Promoting Physical Activity Recommendations for Americans Act; H.R. 2841 - Student Athlete Level Playing Field Act; H.R. 7246, S. 3940 - Student and Student Athlete Opioid Misuse Prevention Act; Name, Image and Likeness issues for college athletes; H.R. 4163 - Even Playing Field Act; H.R. 3320, S. 1679 - Allied Health Workforce Diversity Act; H.R. 1899 - Ensuring Compliance Against Drug Diversion Act of 2021; H.R. 1384/S. 445 - the Synthetic Opioid Danger Awareness Act; H.R. 2355 - Opioid Prescription Verification Act; H.R. 3193 Expanded Telehealth Access Act; S. 4056/H.R. 7478 - Supporting Athletes, Families, and Educators to Protect the Lives of Athletic Youth Act; Athletic trainer salary issues; H.R. 8552 - PLAYS in Youth Sports Act; H.R. 8751 - High School Sports Injury Reporting Act; H.R. 8745 - National Concussion and Traumatic Brain Injury Clearinghouse Act of 2022; S. 4969 - Athlete Opportunity and Taxpayer Integrity Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

Substance use prevention, including naloxone, harm reduction, and Medication for Opioid Use Disorder; Elimination of X waiver; H.R. 1384/S. 445 - Mainstreaming Addiction Treatment Act; Delay Fentanyl scheduling as Schedule 1; S. 5167 TEST Act.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE

Increasing access to mental health and substance use treatment; Mental Health Parity implementation; H.R. 1384/S. 445 - Mainstreaming Addiction and Treatment Act; H.R. 7666 Restoring Hope for Mental Health and Well-Being Act; H.R. 8637/S. 4003 Law Enforcement De-Escalation Act; H.R. 7483 Cost of Mental Illness Act; H.R. 9260 Stop Online Suicide Assisted Forums.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

340B Drug Pricing Program; Chronic disease management; Digital health; Maternal health; Telehealth/telemedicine; COVID-19 response; Health Disparities/Health Inequities; Social Determinants of Health; Health Equity; H.Res.909 - Violence against healthcare workers; Healthcare workforce; Broadband access; Mental Health; Provider economic support; H.R.1384/S.445 - Mainstreaming Addiction Treatment Act of 2021; H.R.7961 - SAVE Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Mainstreaming Addiction Treatment Act ( HR 1384; S 445, PL 117-328, Consolidated Appropriations Act)); Medication Access and Training Expansion Act, (HR 2067, HR 7667, PL 117-328); Reducing Barriers to Substance use Training Act (no bill number in this Congress).

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied for appropriations funding for syringe service providers and to lift the federal ban on syringes. Supported passage of MAT Act (S.445/H.R. 1384) which expands access to medication for people who use drugs.

Client expense: $87,644 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to COVID relief and the provider relief fund. Issues related to health care workforce, maternal health, and behavioral health. Monitored the implementation of H.R. 5376 (P.L. 117-169),the Inflation Reduction Act, as it relates to hospitals. Monitored H.R. 4944, Helping Kids Cope Act of 2021. Monitored H.R. 1384, Mainstreaming Addiction Treatment Act of 2021. H.R.2617, Consolidated Appropriations Act of 2023, as it relates to mental health.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Mainstreaming Addiction Treatment Act of 2021 (H.R. 1384/S.445), provisions related to combatting opioid addiction and elimination of X-waiver. Issues related to drug pricing, drug shortages, and the drug supply chain (generally, no specific legislation). Issues related to COVID-19 response recommendations, including pharmacist provision of testing and vaccination (generally, no specific legislation). Patient access to pharmacist provided vaccinations for COVID/flu/pediatric illnesses, COVID-19 testing, Emergency HIV prophylaxis, initiation of oral antivirals for flu/COVID, Buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation).

Client expense: $270,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

1. Cybersecurity resources for providers 2. Information blocking policies 3. Patient ID - removing congressional ban 4. Telehealth - retaining pandemic flexibilities 5. Broadband - more resources for providers 6. Privacy - reduce duplication with HIPAA 7. Digital Identity Remove Section 510 Labor-HHS Appropriations (patient ID) HR 1848 - LIFT America Act (cyber) - To rebuild and modernize the Nations infrastructure to expand access to broadband and Next Generation 9-1-1, rehabilitate drinking water infrastructure, modernize the electric grid and energy supply infrastructure, redevelop brownfields, strengthen health care infrastructure, create jobs, and protect public health and the environment, and for other purposes H.R.1332 - Telehealth Modernization Act S.1512 - CONNECT for Health Act of 2021 H.R. 6000, the Cures 2.0 Act. Patch Act, HR 7084 and S 3983 Mainstreaming Addiction Treatment Act (MAT Act, H.R. 1384 / S. 445) HR 8152 - American Data Privacy and Protection Act H.R.4040 - Advancing Telehealth Beyond COVID-19 Act of 2021 H.R. 8806 - Healthcare Cybersecurity Act of 2022 S 3904 - Healthcare Cybersecurity Act of 2022 e S. 4528 - Improving Digital Identity Act of 2022

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institute of Standards & Technology (NIST), SENATE, Treasury, Dept of

1. Cybersecurity resources for providers 2. Information blocking policies 3. Patient ID - removing congressional ban 4. Telehealth - retaining pandemic flexibilities 5. Broadband - more resources for providers 6. Privacy - reduce duplication with HIPAA 7. Digital Identity Remove Section 510 Labor-HHS Appropriations (patient ID) HR 1848 - LIFT America Act (cyber) - To rebuild and modernize the Nations infrastructure to expand access to broadband and Next Generation 9-1-1, rehabilitate drinking water infrastructure, modernize the electric grid and energy supply infrastructure, redevelop brownfields, strengthen health care infrastructure, create jobs, and protect public health and the environment, and for other purposes H.R.1332 - Telehealth Modernization Act S.1512 - CONNECT for Health Act of 2021 H.R. 6000, the Cures 2.0 Act. Patch Act, HR 7084 and S 3983 Mainstreaming Addiction Treatment Act (MAT Act, H.R. 1384 / S. 445) HR 8152 - American Data Privacy and Protection Act H.R.4040 - Advancing Telehealth Beyond COVID-19 Act of 2021 H.R. 8806 - Healthcare Cybersecurity Act of 2022 S 3904 - Healthcare Cybersecurity Act of 2022 e S. 4528 - Improving Digital Identity Act of 2022

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institute of Standards & Technology (NIST), SENATE, Treasury, Dept of

Support for public health infrastructure Personal Protective Equipment Standards and access to Personal Protective Equipment, including supply chain issues Mental health resources for nurses S.308/H.R.1436 - PPE in America Act H.R. 1384/S.445 - Mainstreaming Addiction Treatment (MAT) Act Issues surrounding telehealth, including removal of Medicare originating site and rural area restrictions S.610/H.R.1667 - Dr. Lorna Breen Health Care Provider Protection Act H.R. 851/S.246 - Future Advancement of Academic Nursing (FAAN) Act Issues surrounding nurse staffing shortages and remedies to address this crisis Pandemic preparedness S.3799 - PREVENT Pandemics Act Extension of COVID-19 public health emergency H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S. 5212/H.R. 8812 - Improving Care and Access to Nurses (ICAN) Act Issues surrounding federal Monkeypox response

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 411: MOMMA Act - Improve data collection, interventions, and expanded access for postpartum women S. 464/HR 2163: Safe Step Act-Implement transparency guidelines for step-therapy utilization S.1975/H.R. 3755: Womens Health Protection Act - Protect patient-physician relationship by allowing physicians to provide evidence-based womens health care S.1988: Protecting Rural Teleheath Access Act - Waive geographic restrictions and offer audio-only appointments S. 1893: Rural Physician Workforce Production Act - Provide federal support for rural residency training S1958/HR3671:DOC Act - Permanent authorization of THCGME program HR 379 Improving Social Determinants of Health Act: Would create a new SDoH program at the CDC HR 959: Black Maternal Health Momnibus Act - Comprehensive reforms to address maternal health challenges HR 976: Ensuring Transparent Honest Information on COVID-19 Act - Requires COVID-19 data reporting, including demographic information to the CDC, by states & localities & funds a study to examine public health data & infrastructure during & after the COVID-19 PHE. HR 1319: American Rescue Plan - Expansion of ACA coverage, investments in public health workforce, funding for COVID-19 response HR 1384: Mainstreaming Addiction Treatment Act of 2021- Eliminated the x-waiver HR 1848: LIFT America Act - Enhancing public health infrastructure, improve laboratory infrastructure, update care facilities, improve broadband infrastructure, and address social determinants of health HR 2125: Quit Because of Covid 19 Act - Would ensure that all Medicaid and CHIP enrollees have access to proven tobacco cessation treatments. HR 2347: Strengthening Vaccines for Childrens Act - Modifications to improve the Vaccine for Children (VFC) program HR 2418: Student Loan Forgiveness for Frontline Health Workers- Would forgive outstanding federal and private student loan debt for frontline physicians H.R. 5218: Collaborate in an Orderly and Cohesive Manner Act H.R. 4387/S.1675: Maternal Health Quality Improvement Act H.R. 5054: Physicians Serving Patients Act of 2021 H.R. 4770: Evaluating Disparities and Outcomes of Telehealth During the COVID-19 Emergency Act H.R. 5376: Build Back Better Act H.R. 4387/S. 1675: Maternal Health Quality Improvement Act H.R. 5218: Collaborate in an Orderly and Cohesive Manner Act H.R. 5541: Primary and Virtual Care Affordability Act S. 128: Primary Care Enhancement Act No Bill No: Physicians Serving Patients Act of 2021 No Bill No.: Congressional Primary Care Caucus;117th Congress membership in the bipartisan CPCC No Bill No.: Teaching Health Centers GME; Community Health Centers- National Health Service Corps; Special Diabetes Program; Special Diabetes Program for Indians - Increased funding and allocation of resources for teaching health center programs No Bill No.: Primary Care Patient Protection Act - Create a primary care benefit in high deductible health plans No Bill No.: No Surprise Bills for New Moms - Require health plans to cover newborns under mothers coverage for set time, SEP for enrollment post childbirth, and notification requirements No Bill No.: FY 2022 Appropriations Requests - CDC Programs (Climate/Health; Gun Violence Research; vaccine infrastructure); HRSA; AHRQ; CMS No Bill No.: Rural MOMS Act-Demonstration program to train physicians about maternal care in rural communities No Bill No.: COVID-19 Safe Birthing Act-Expand maternal telehealth for Medicaid beneficiaries; Medicaid/CHP post-partum coverage extension to one year No Bill No.: Anti-Racism in Public Health Act-Direct CDC to declare racism a public health crisis; establish a CDC-based center for addressing violence prevention No Bill No.: Equality Act-Provide affirmative, statutory nondiscrimination protections for LGBTQ Americans No Bill No.: Covid 19 vaccinations - Ensure Primary Care Physicians can access COVID-19 vaccines. No Bill No.: Telehealth Expansion - Preserve key telehealth flexibilities beyond COVID-19 PHE Affordable Insulin Now Act FY22 COVID-19 supplemental H.R. 7232: 9-8-8 and Parity Assistance Act Prevent Pandemics Act H.R. 7076: Supporting Children's Mental Health Care Access Act H.R. 3085: Equity in Neuroscience and Alzheimer's Clinical Trials Act H.R. 6584: Diverse and Equitable Participation in Clinical Trials Act H.R. 4122/S. 3658: REDI Act H.R. 1667: Dr. Lorna Breen Health Care Provider Protection Act S. 1893: Workforce Production Act of 2021 H.R. 7894/S.4347: Affordability is Access Act H.R. 8297: Ensuring Access to Abortion Act S.4306: Improving Access to Behavioral Health Integration Act S. 4170: Mental Health Reform Reauthorization Act H.R. 7666: Restoring Hope for Mental Health and Well-Being Act H.R. 7232: 9-8-8 and Parity Assistance Act H.R. 7076: Supporting Children's Mental Health Care Access Act S. 4408: Health and Location Data Protection Act No Bill No.: Behavioral health integration w/i primary care H.R. 5376: Inflation Reduction Act S. 198: Data Mapping to Save Moms' Lives Act H.R. 4040: Advancing Telehealth Beyond COVID-19 Act of 2021 Consolidated Appropriations Act of 2023

Client expense: $788,015 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Inflation Reduction Act of 2022, PL 117-169 (issues related to pharmaceutical treatments for opioid use disorders). HR 7666-the Restoring Hope for Mental Health and Well Being Act of 2022. HR 1384-Mainstreaming Addiction Treatment Act of 2021. HR 2067-MATE Act of 2021. HR 955/S.285-Medicare Reentry Act of 2021. Substance abuse treatment in correctional facilities.

Client expense: Not reported · Firm income: $60,000

Government targets: Justice, Dept of (DOJ), SENATE, White House Office

H.R. 2067/S.2235 - Medication Access and Training Expansion (MATE) Act H.R. 1384/S.445 - Mainstreaming Addiction Treatment (MAT) Act Reducing regulatory and legislative barriers for Nurse Practitioners Include nurses, APRNs, and nursing students in all National Public Health Plans Issues surrounding nurse faculty shortages H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 Rural health care access Issues pertaining to White House Hunger, Nutrition, and Health Conference Public Law No: 117-215 - Medical Marijuana and Cannabidiol Research Expansion Act (H.R. 8454) S. 5212/H.R. 8812 - Improving Care and Access to Nurses (ICAN) Act Issues surrounding federal Monkeypox response H.R.2617 - Consolidated Appropriations Act, 2023

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Substance Use Disorders, Training related issues Medication Assisted Treatment (MAT) delivery related issues H.R.6279/S.3629, Opioid Treatment Access Act, Entirety H.R.1384/S.445, Mainstreaming Addiction Treatment Act of 2021, Entirety H.R.2067, Medication Access and Training Expansion Act, Entirety H.R.7666, Restoring Hope for Mental Health and Well-Being Act of 2022, Entirety Public Law 117-328, Consolidated Appropriations Act, FY2023, Health; Mental Health; and Substance Use Disorder (SUD) related issues Monitor Telehealth for providing Medication Assisted Treatment (MAT)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Substance Use Disorders, Training related issues Medication Assisted Treatment (MAT) delivery related issues H.R.6279/S.3629, Opioid Treatment Access Act, Entirety H.R.1384/S.445, Mainstreaming Addiction Treatment Act of 2021, Entirety H.R.2067, Medication Access and Training Expansion Act, Entirety H.R.7666, Restoring Hope for Mental Health and Well-Being Act of 2022, Entirety Public Law 117-328, Consolidated Appropriations Act, FY2023, Health; Mental Health; and Substance Use Disorder (SUD) related issues Monitor Telehealth for providing Medication Assisted Treatment (MAT)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.6279/S.3629, Opioid Treatment Access Act, Entirety H.R.7666, Restoring Hope for Mental Health and Well-Being Act of 2022, Entirety Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) H.R. 2067, Medication Access and Training Expansion Act Public Law 117-328, Conslidated Appropriations Act, FY2023, Health and Mental Health related issues Monitor the following: H.R.8454/S.253, Medical Marijuana and Cannabidiol Research Expansion Act, Entirety S.4839, State Opioid Response Grant Authorization Act, Entirety Mental Health Substance Use Disorder related issues H.R.5218, Collaborate in an Orderly and Cohesive Manner Act, Entirety S.4591, Cannabis Administration and Opportunity Act, generally H.R.1384/S.445, Mainstreaming Addiction Treatment Act S.987, CARA 3.0 Act of 2021

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.6279/S.3629, Opioid Treatment Access Act, Entirety H.R.7666, Restoring Hope for Mental Health and Well-Being Act of 2022, Entirety Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) H.R. 2067, Medication Access and Training Expansion Act Public Law 117-328, Conslidated Appropriations Act, FY2023, Health and Mental Health related issues Monitor the following: H.R.8454/S.253, Medical Marijuana and Cannabidiol Research Expansion Act, Entirety S.4839, State Opioid Response Grant Authorization Act, Entirety Mental Health Substance Use Disorder related issues H.R.5218, Collaborate in an Orderly and Cohesive Manner Act, Entirety S.4591, Cannabis Administration and Opportunity Act, generally H.R.1384/S.445, Mainstreaming Addiction Treatment Act S.987, CARA 3.0 Act of 2021

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MAT Act- Mainstreaming Addiction Treatment- H.R.1384, S.445

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities. Advocated for S 2235/HR 2067 - Medication Access and Training Expansion (MATE) Act of 2021: This legislation would ensure most Drug Enforcement Agency (DEA) controlled medication prescribers have a baseline knowledge of how to identify, treat, and manage patients with SUD and would allow accredited health professional schools and residency programs to fulfill the training requirement through their own curricula, as well as provide them with resources to do so. Advocated for simultaneous passage of S 445/HR 1384 - Mainstreaming Addiction Treatment (MAT) Act, which would eliminate the requirement that practitioners apply for a separate waiver through the DEA to prescribe buprenorphine for addiction and eliminate the patient limits on buprenorphine prescribers. Advocated for S 285/HR 955 - the Medicaid Reentry Act: This legislation would allow for reestablishment of health insurance coverage under Medicaid for eligible individuals who are incarcerated, during the 30-day period preceding their release from jail or prison. Advocated for S.2697/H.R.6636 - the Due Process Continuity of Care Act: This legislation would amend the Medicaid Inmate Exclusion Policy to allow these otherwise eligible individuals to receive their full Medicaid benefits while incarcerated at the option of the state. Advocated for the DEA and SAMHSA to grant continued telehealth flexibilities for buprenorphine for OUD during the national public health emergency declared in response to the opioid crisis and work to make those telehealth flexibilities permanent, as appropriate, based on findings of further studies. Advocated for the Office of National Drug Control Policy (ONDCP) to clear policy barriers to sustainable implementation of contingency management (CM) interventions. Advocated for HR 1364/S.4804 - the Parity Enforcement Act: This legislation would expand the U.S. Department of Labors authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 or for employing utilization review processes that prove more restrictive for mental health and addiction care than for other medical care in violation of the MHPAEA. Advocated for S 340/HR 1674 - TREATS Act: This legislation would make permanent a new, audio-video, telehealth evaluation exception to the Ryan Haight Acts in-person exam requirement, which would allow clinicians to prescribe certain addiction treatment medications, like buprenorphine, to new patients through telehealth. Advocated for HR 6279/S 3629 - Opioid Treatment Access Act which would make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers. Advocated for passage of HR 3441/ S 1438 the Opioid Workforce Act/Substance Use Disorder Workforce Act to increase Medicare supported GME slots for addiction medicine, addiction psychiatry, and pain medicine. Advocated for draft legislative text that would close severe MH/SUD coverage gaps in Medicare. Advocated for issuance of a NPRM regarding further alignment of 42 CFR Part 2 with HIPAA, as called for by the CARES Act. Advocated for federal agency guidance on CAPTA reporting vs. notification requirements and inclusion of S. 1927, the Child Abuse Prevention and Treatment (CAPTA) Reauthorization Act of 2021, in an end-of-the-year legislative package. ASAM joined a letter addressed to the Chairs and Ranking Members of the Labor, Health and Human Services, Education, and Related Agencies Subcommittees of the U.S. Senate and House Committees on Appropriations, urging the committees to fund the Centers for Disease Control and Preventions (CDC) Office of Smoking and Health (OSH) at $261.5 million, as was delineated in the U.S. Senate Appropriations Committees Chairmans mark from July 2022 ASAM submitted comments in a letter to the U.S. Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Committee on Health, Education, Labor and Pensions (HELP), containing policy recommendations for inclusion in a possible Senate mental health and substance use disorder (MH/SUD) legislative package. The comments were based on HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022, which has already passed the U.S. House on a bipartisan basis. The letter voices ASAM's support for many provisions of the Restoring Hope Act, that would, among other things, reauthorize key Substance Abuse and Mental Health Administration (SAMHSA) and Health Resources and Services Administration (HRSA) programs to address the national MH and SUD crisis. ASAM joined a letter to the U.S. Senate Finance Committee in response to the committees Enhancing the Mental Health Workforce discussion draft. The letter thanks the committee for its ongoing efforts to address the MH and SUD workforce crisis and makes several key recommendations. The letters recommendations focus on two key areas: (1) clarifications to the bills language to ensure that Medicare beneficiaries with a primary diagnosis of SUD or no co-occurring MH condition can access the critical services they need and (2) resolving other barriers that prevent the MH and SUD workforce from meeting its full potential. ASAM joined a letter to SAMHSA supporting continuation of the PCSS program

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)